Association of Gut Microbiota-Related Metabolites and Type 2 Diabetes in Two Puerto Rican Cohorts
-
Published:2024-03-27
Issue:7
Volume:16
Page:959
-
ISSN:2072-6643
-
Container-title:Nutrients
-
language:en
-
Short-container-title:Nutrients
Author:
Sawicki Caleigh M.12, Pacheco Lorena S.3ORCID, Rivas-Tumanyan Sona4ORCID, Cao Zheyi2ORCID, Haslam Danielle E.13ORCID, Liang Liming5, Tucker Katherine L.6ORCID, Joshipura Kaumudi4, Bhupathiraju Shilpa N.13
Affiliation:
1. Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, 181 Longwood Ave, Boston, MA 02115, USA 2. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA 3. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA 4. Department of Surgical Sciences, School of Dental Medicine, University of Puerto Rico, San Juan, PR 00921, USA 5. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA 6. Department of Biomedical and Nutritional Sciences and Center for Population Health, University of Massachusetts, Lowell, MA 01854, USA
Abstract
(1) Aims: Gut microbiota metabolites may play integral roles in human metabolism and disease progression. However, evidence for associations between metabolites and cardiometabolic risk factors is sparse, especially in high-risk Hispanic populations. We aimed to evaluate the cross-sectional and longitudinal relationships between gut microbiota related metabolites and measures of glycemia, dyslipidemia, adiposity, and incident type 2 diabetes in two Hispanic observational cohorts. (2) Methods: We included data from 670 participants of the Boston Puerto Rican Health Study (BPRHS) and 999 participants of the San Juan Overweight Adult Longitudinal Study (SOALS). Questionnaires and clinical examinations were conducted over 3 years of follow-up for SOALS and 6 years of follow-up for BPRHS. Plasma metabolites, including L-carnitine, betaine, choline, and trimethylamine N-oxide (TMAO), were measured at baseline in both studies. We used multivariable linear models to evaluate the associations between metabolites and cardiometabolic risk factors and multivariable logistic and Poisson regressions to assess associations with prevalent and incident type 2 diabetes, adjusted for potential confounding factors. Cohort-specific analyses were combined using a fixed-effects meta-analysis. (3) Results: Higher plasma betaine was prospectively associated with lower fasting glucose [−0.97 mg/dL (95% CI: −1.59, −0.34), p = 0.002], lower HbA1c [−0.02% (95% CI: −0.04, −0.01), p = 0.01], lower HOMA-IR [−0.14 (95% CI: −0.23, −0.05), p = 0.003], and lower fasting insulin [−0.27 mcU/mL (95% CI: −0.51, −0.03), p = 0.02]. Betaine was also associated with a 22% lower incidence of type 2 diabetes (IRR: 0.78, 95% CI: 0.65, 0.95). L-carnitine was associated with lower fasting glucose [−0.68 mg/dL (95% CI: −1.29, −0.07), p = 0.03] and lower HbA1c at follow-up [−0.03% (95% CI: −0.05, −0.01), p < 0.001], while TMAO was associated with higher fasting glucose [0.83 mg/dL (95% CI: 0.22, 1.44), p = 0.01] and higher triglycerides [3.52 mg/dL (95% CI: 1.83, 5.20), p < 0.0001]. Neither choline nor TMAO were associated with incident type 2 diabetes. (4) Conclusions: Higher plasma betaine showed consistent associations with a lower risk of glycemia, insulinemia, and type 2 diabetes. However, TMAO, a metabolite of betaine, was associated with higher glucose and lipid concentrations. These observations demonstrate the importance of gut microbiota metabolites for human cardiometabolic health.
Funder
National Institutes of Health NRSA Harvard T.H. Chan School of Public Health
Reference56 articles.
1. The Impact of the Gut Microbiota on Human Health: An Integrative View;Clemente;Cell,2012 2. A metagenome-wide association study of gut microbiota in type 2 diabetes;Qin;Nature,2012 3. Gut metagenome in European women with normal, impaired and diabetic glucose control;Karlsson;Nature,2013 4. Composition of gut microbiota and its correlations with neurological, intestinal, cardiovascular and metabolic diseases;Sciuto;Acta Microbiol. Immunol. Hung.,2023 5. GBD 2017 Causes of Death Collaborators (2018). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392, 1736–1788.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|